Indocyanine green
Drugindocyanine green (INFRACYANINE© 25mg/10mL).
NCT Number: NCT04842162
Assess the sensitivity of real-time near-infrared fluorescence imaging to detect microscopic residual disease in the operating room after a complete macroscopic surgical resection of head and neck cancers
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 2
Institut Jules Bordet, Anderlecht, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
indocyanine green (INFRACYANINE© 25mg/10mL).
Time frame: at surgery
Sensitivity of real-time near-infrared fluorescence imaging to detect microscopic residual disease in the operating room after complete macroscopic surgical resection.
For the calculation of the sensitivity, for each operating room we consider the first section and the last section in which the pathological analysis confirms the presence of microscopic residual disease. Patients for whom near-infrared fluorescence imaging detects disease are classified as true positives (TP). Sensitivity is defined as the number of TP divided by the total number of patients N.
Contact information is provided by the study sponsor or research team.
Gustave Roussy, Cancer Campus, Grand Paris
Other
Acronym: MAGNOLIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06239220
Carcinoma, Carcinoma, Squamous Cell
Boston, Massachusetts, United States
View Trial DetailsNCT06970275
Breast Cancer, Breast Diseases
Ghent, Belgium
View Trial DetailsNCT07726407
Head and Neck Cancer, Head and Neck Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT07124000
Adenocarcinoma, Adenocarcinoma (NOS)
Birmingham, Alabama, United States
View Trial Details